Webinar: Reaching Zero-dose Children in Humanitarian Contexts

 

View this email in your browser
IVAC Webinar Series

February 2022
Johns Hopkins University
Bloomberg School of Public Health

Register Today for Webinar on Reaching Zero-Dose Children and Supporting Immunization Equity in Humanitarian Contexts 

 

 
Register Now

When: March 28, 2022 14:00-15:00 CET |  8:00-9:00am EDT 

How do we restore and strengthen immunization to effectively reach populations in humanitarian settings? An estimated two-thirds of zero-dose children live in conflict-affected settings. More broadly, countries that are considered as fragile and conflict-affected states by the World Bank and IMF are home to nearly one billion people, nearly double the level 20 years ago. Research suggests that global conflicts are lasting longer and becoming more complex with greater impacts on civilian populations.

It is within this context that Gavi is currently revising its Fragility, Emergencies and Refugees Policy and will be inviting stakeholders to engage via a public consultation from 25 March to 1 April 2022. Alongside this, Gavi and IVAC have partnered to organize a zero dose-focused webinar. A panel of humanitarian and immunization experts will discuss the importance of prioritizing immunization equity in humanitarian settings and key issues for maintaining routine services including childhood immunization. The discussion will also explore what Gavi and partners are doing to reach the most marginalized children.

Panelists:

  • Amy LaTrielle, MBA, Director, Fragile and Conflict Countries at Gavi, the Vaccine Alliance
  • Ann Burton, MD, MPH, Chief of the Public Health Section, UNHCR
  • Gilbert Burnham, MD, PhD, MSc, Professor – Emeritus, Johns Hopkins Bloomberg School of Public Health
  • William Moss, MD, MPH, Executive Director, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health
 
 
Copyright © 2021 IVAC, All rights reserved.

For Media Inquiries, contact:
This email address is being protected from spambots. You need JavaScript enabled to view it.


image    image
Twitter
Website
Facebook